Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2012

Oct 26, 2012

30718_dirs_2012-10-26_cc2f4322-0ba1-4f69-82e7-0e2f924851dc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2012-10-25

Reporting Person: HOLBROOK KAREN A (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-10-25 Stock Option $66.9 A 5000 Acquired 2022-10-24 Common Stock (5000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $70.35 2021-10-26 Common Stock (5000) 5000 Direct
Stock Option $61.46 2020-10-27 Common Stock (5000) 5000 Direct
Stock Option $63.03 2019-10-28 Common Stock (5000) 5000 Direct
Stock Option $65.47 2018-10-22 Common Stock (5000) 5000 Direct
Stock Option $66.59 2017-10-24 Common Stock (5000) 5000 Direct
Stock Option $57.06 2017-02-11 Common Stock (10000) 10000 Direct